Toyota Yasunori, Miyake Keisuke, Kawai Nobuyuki, Hatakeyama Tetsuhiro, Yamamoto Yuka, Toyohara Jun, Nishiyama Yoshihiro, Tamiya Takashi
Department of Neurological Surgery, Faculty of Medicine, Kagawa University, Kagawa, 761-0793 Japan.
Department of Radiology, Faculty of Medicine, Kagawa University, Kagawa, 761-0793 Japan.
EJNMMI Res. 2015 Mar 5;5:7. doi: 10.1186/s13550-015-0085-3. eCollection 2015.
3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) has been used to evaluate tumor malignancy and cell proliferation in human brain gliomas. However, (18)F-FLT has several limitations in clinical use. Recently, (11)C-labeled thymidine analogue, 4'-[methyl-(11)C]thiothymidine ((11)C-4DST), became available as an in vivo cell proliferation positron emission tomography (PET) tracer. The present study was conducted to evaluate the usefulness of (11)C-4DST PET in the diagnosis of human brain gliomas by comparing with the images of (18)F-FLT PET.
Twenty patients with primary and recurrent brain gliomas underwent (18)F-FLT and (11)C-4DST PET scans. The uptake values in the tumors were evaluated using the maximum standardized uptake value (SUVmax), the tumor-to-normal tissue uptake (T/N) ratio, and the tumor-to-blood uptake (T/B) ratio. These values were compared among different glioma grades. Correlation between the Ki-67 labeling index and the uptake values of (11)C-4DST and (18)F-FLT in the tumor was evaluated using linear regression analysis. The relationship between the individual (18)F-FLT and (11)C-4DST uptake values in the tumors was also examined.
(11)C-4DST uptake was significantly higher than that of (18)F-FLT in the normal brain. The uptake values of (11)C-4DST in the tumor were similar to those of (18)F-FLT resulting in better visualization with (18)F-FLT. No significant differences in the uptake values of (18)F-FLT and (11)C-4DST were noted among different glioma grades. Linear regression analysis showed a significant correlation between the Ki-67 labeling index and the T/N ratio of (11)C-4DST (r = 0.50, P < 0.05) and (18)F-FLT (r = 0.50, P < 0.05). Significant correlations were also found between the Ki-67 labeling index and the T/B ratio of (11)C-4DST (r = 0.52, P < 0.05) and (18)F-FLT (r = 0.55, P < 0.05). A highly significant correlation was observed between the individual T/N ratio of (11)C-4DST and (18)F-FLT in the tumor (r = 0.79, P = 0.0001).
The present study demonstrates that (11)C-4DST is useful for the imaging of human brain gliomas with PET. A relatively higher background uptake of (11)C-4DST in the normal brain compared to (18)F-FLT limits the detection of low-tracer-uptake tumors. Moreover, no superiority was found in (11)C-4DST over (18)F-FLT in the evaluation of cell proliferation.
3'-脱氧-3'-[(18)F]氟胸苷((18)F-FLT)已被用于评估人脑胶质瘤的肿瘤恶性程度和细胞增殖情况。然而,(18)F-FLT在临床应用中有几个局限性。最近,(11)C标记的胸苷类似物4'-[甲基-(11)C]硫代胸苷((11)C-4DST)作为一种体内细胞增殖正电子发射断层扫描(PET)示踪剂可供使用。本研究旨在通过与(18)F-FLT PET图像比较,评估(11)C-4DST PET在人脑胶质瘤诊断中的有用性。
20例原发性和复发性脑胶质瘤患者接受了(18)F-FLT和(11)C-4DST PET扫描。使用最大标准化摄取值(SUVmax)、肿瘤与正常组织摄取(T/N)比以及肿瘤与血液摄取(T/B)比评估肿瘤中的摄取值。比较不同胶质瘤分级之间的这些值。使用线性回归分析评估肿瘤中Ki-67标记指数与(11)C-4DST和(18)F-FLT摄取值之间的相关性。还检查了肿瘤中个体(18)F-FLT和(11)C-4DST摄取值之间的关系。
在正常脑中,(11)C-4DST摄取显著高于(18)F-FLT。肿瘤中(